Literature DB >> 21777473

Resource flows and levels of spending for the response to HIV and AIDS in Belarus.

Valentina I Kachan1, Alena I Tkachova, Eleanora Gvozdeva, Ilona Urbanovich, Anna Yakusik, Peter Amico, Carlos Avila-Figueroa.   

Abstract

BACKGROUND: Belarus has a focused HIV epidemic concentrated among injecting drug users, female sex workers and men who have sex with men. However, until 2008, Belarus had no way of evaluating HIV spending priorities. In 2008, Belarus committed to undertaking a comprehensive National AIDS Spending Assessment (NASA) in order to analyze HIV spending priorities. NASA was used to 'follow the money' from the funding sources to agents and providers, and eventually to beneficiary populations.
FINDINGS: Belarus spent the majority of its funding on prevention, diagnosis and treatment of sexually transmitted infections and on securing the blood supply. International donors and NGOs working within Belarus spent the majority of their funding on preventative activities for high risk groups while Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM) solely funded antiretroviral treatment.
CONCLUSIONS: The data and experience obtained through conducting NASA will help build capacity for future resource tracking activities for HIV and other health priorities. This experience established the foundation for enhanced and future consistent quality-reporting of National Health Accounts. Monitoring the flow of resources for Belarus' HIV response provides valuable strategic information that can improve operations and planning as well as mobilize greater resources. NASA offers Belarusian policy makers an overview of HIV activities that merit their priority attention. In addition, the findings from Belarus are particularly relevant for the rest of the Commonwealth of Independent States due to their similar epidemiological profiles and centrally planned systems. The Belarusian government faces future challenges, especially in increasing public investments in HIV prevention for female sex workers and their clients, men who have sex with men, and among intravenous drug users.

Entities:  

Year:  2011        PMID: 21777473      PMCID: PMC3156755          DOI: 10.1186/1756-0500-4-248

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


  9 in total

1.  Public health. Global HIV/AIDS policy in transition.

Authors:  John Bongaarts; Mead Over
Journal:  Science       Date:  2010-06-11       Impact factor: 47.728

2.  Laboratory diagnosis of sexually transmitted infections in Belarus.

Authors:  Oleg Pankratov; Iryna Shimanskaya; Valentin Pankratov; Alexandr Navrotsky; Ronald C Ballard; Magnus Unemo; Marius Domeika
Journal:  Acta Derm Venereol       Date:  2011-01       Impact factor: 4.437

Review 3.  Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009-31.

Authors:  Robert Hecht; John Stover; Lori Bollinger; Farzana Muhib; Kelsey Case; David de Ferranti
Journal:  Lancet       Date:  2010-10-09       Impact factor: 79.321

4.  Estimating the level of HIV prevention coverage, knowledge and protective behavior among injecting drug users: what does the 2008 UNGASS reporting round tell us?

Authors:  Bradley M Mathers; Louisa Degenhardt; Philippe Adam; Igor Toskin; Magomed Nashkhoev; Rob Lyerla; Deborah Rugg
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

5.  Financing the response to HIV in low-income and middle-income countries.

Authors:  José Antonio Izazola-Licea; Jan Wiegelmann; Christian Arán; Teresa Guthrie; Paul De Lay; Carlos Avila-Figueroa
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

6.  Critical choices in financing the response to the global HIV/AIDS pandemic.

Authors:  Robert Hecht; Lori Bollinger; John Stover; William McGreevey; Farzana Muhib; Callisto Emas Madavo; David de Ferranti
Journal:  Health Aff (Millwood)       Date:  2009 Nov-Dec       Impact factor: 6.301

7.  The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus.

Authors:  Lilani Kumaranayake; Peter Vickerman; Damian Walker; Syiatsaslav Samoshkin; Vladimir Romantzov; Zoya Emelyanova; Victor Zviagin; Charlotte Watts
Journal:  Addiction       Date:  2004-12       Impact factor: 6.526

8.  Progress in global blood safety for HIV.

Authors:  Teiji Takei; Noryati Abu Amin; George Schmid; Neelam Dhingra-Kumar; Deborah Rugg
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

9.  AIDS in Latin America: assessing the current status of the epidemic and the ongoing response.

Authors:  Francisco I Bastos; Carlos Cáceres; Jane Galvão; Maria Amélia Veras; Euclides Ayres Castilho
Journal:  Int J Epidemiol       Date:  2008-08       Impact factor: 7.196

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.